Health & Fitness
Health and Fitness
Health and Fitness
Thu, February 26, 2009 Invitrogen Earns AmeriStar Award for GIBCO Cell Culture Bottle Design
CARLSBAD, Calif.--([ BUSINESS WIRE ])--Invitrogen, a division of Life Technologies (NASDAQ:LIFE), today announced that it has received the prestigious AmeriStar® Package Award from the Institute of Packaging Professionals for its new [ GIBCO® cell culture bottle ]. Invitrogen launched the redesigned GIBCO bottle in October of last year to offer scientists improved ease of use, storage efficiency, and reduced sample contamination for their cell culture experiments.
The new bottle is the result of three years of collaborative research and development between Invitrogen and global design consultancy IDEO that involved testing more than 30 prototypes, and container manufacturer Graham Packaging Plastics, which helped develop the manufacturing plan for the innovative bottle design. The end result was a redesigned bottle that provides improved ergonomics of the "under-the-hood" workflow, superior handling and storage, easier identification, and additional room for supplements.
"This honor recognizes our corporate commitment to customer-driven innovation," said Todd Laird, Vice President and General Manager of the Invitrogen Cell Culture Essentials Business Unit. "After extensive observations of scientists conducting cell culture workflow experiments, our team developed a new solution that resulted in a true breakthrough in user-centric design that transforms the way scientists work."
AmeriStar evaluated more than 100 packages in 15 different categories, with the GIBCO bottle receiving honors for the medical device category. A formal awards ceremony will take place May 19 as part of the IoPP Annual Packaging Summit in Chicago.
In the past year, Life Technologies has earned numerous industry awards through its Invitrogen and Applied Biosystems divisions. Highlights include: six [ Life Science Industry Awards ] for Invitrogen; The Scientist magazine's [ Life Science Innovation of the Year Award ] for the Applied Biosystems SOLiD™ System for next-generation sequencing; and SelectScience's[ Best New Life Science Product ] for the Applied Biosystems StepOne™ Real-time PCR System.
Invitrogen is a leading provider of platform independent, essential life science technologies for disease and drug research, bioproduction and diagnostics. It is the leading global supplier of cell culture research products and services for the advancement of stem cell research and regenerative medicine. Invitrogen, together with Applied Biosystems – a global leader in providing innovative instrument systems to accelerate academic and clinical research, drug discovery and development, pathogen detection and forensic DNA – is part of Life Technologies Corporation, which markets the life science industry's most comprehensive portfolio of solutions for molecular and cell biology. Invitrogen and Applied Biosystems products are used in nearly every major laboratory in the world. For more information, please visit: [ www.appliedbiosystems.com ] and [ www.invitrogen.com ].
Additional Resources:
[ GIBCO Cell Culture Products ]
About Life Technologies
Life Technologies Corporation (NASDAQ: LIFE) is a global biotechnology tools company dedicated to improving the human condition. Our systems, consumables and services enable researchers to accelerate scientific exploration, driving to discoveries and developments that make life even better. Life Technologies customers do their work across the biological spectrum, working to advance personalized medicine, regenerative science, molecular diagnostics, agricultural and environmental research, and 21st century forensics. Life Technologies had sales of more than $3 billion in 2008, employs approximately 9,500 people, has a presence in more than 100 countries, and possesses a rapidly growing intellectual property estate of approximately 3,600 patents and exclusive licenses. Life Technologies was created by the combination of Invitrogen Corporation and Applied Biosystems Inc. For more information on how we are making a difference please visit our website: [ www.lifetechnologies.com ].
Safe Harbor Statement
This press release includes forward-looking statements about our anticipated results that involve risks and uncertainties. Some of the information contained in this press release, including, but not limited to, statements as to industry trends and Life Technologies' plans, objectives, expectations and strategy for its business, contains forward-looking statements that are subject to risks and uncertainties that could cause actual results or events to differ materially from those expressed or implied by such forward-looking statements. Any statements that are not statements of historical fact are forward-looking statements. When used, the words "believe," "plan," "intend," "anticipate," "target," "estimate," "expect" and the like, and/or future tense or conditional constructions ("will," "may," "could," "should," etc.), or similar expressions, identify certain of these forward-looking statements. Important factors which could cause actual results to differ materially from those in the forward-looking statements are detailed in filings made by Life Technologies with the Securities and Exchange Commission. Life Technologies undertakes no obligation to update or revise any such forward-looking statements to reflect subsequent events or circumstances.
For Research Use Only. Not for use in diagnostic procedures.
Copyright 2009. Life Technologies Corporation. All rights reserved. Invitrogen (Design), Invitrogen, Applied Biosystems, and GIBCO are registered trademarks, and SOLiD and StepOne are trademarks, of Life Technologies or its subsidiaries in the United States and/or certain other countries.
Photos/Multimedia Gallery Available: [ http://www.businesswire.com/cgi-bin/mmg.cgi?eid=5905103&lang=en ]
